同仁堂 (600085)

Beijing Tongrentang Co., Ltd.

ASH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 137147.03
  • Circulating A-Shares(W): 137147.03
  • Earnings Per Share(RMB): 0.8590
  • Net Assets Per Share(RMB): 9.9626
  • Operating Revenue(W RMB): 1330791.48
  • Total Profit(W RMB): 195914.60
  • **Net Profit Attributable to Parent(W RMB) **: 117755.58
  • Net Profit Growth Rate(%): -12.78
  • Weighted Return on Equity(%): 8.7200
  • Operating Cash Flow Per Share(RMB): 1.4490
  • Undistributed Profit Per Share(RMB): 6.4733
  • Capital Reserve Per Share(RMB): 1.4220

2. Main Business

The main business covers:

  • Pharmaceutical manufacturing
  • Traditional Chinese medicine production and sales

3. Company Basic Information

  • Company Name: Beijing Tongrentang Co., Ltd.
  • Listing Date: 1997-06-25
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 33 Tiangui Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing
  • Website: gf.tongrentang.com
  • Company Profile: The company's predecessor was China Beijing Tongrentang Group Company. In 1997, it converted its production and operating net assets into 150 million state-owned legal person shares. After the issuance on May 29, 1997, the total share capital reached 200 million shares. Its 5 million internal employee shares will be listed six months after the 45 million public shares were listed on June 25, 1997.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 China Beijing Tongrentang (Group) Co., Ltd. General Legal Person 71930.85 52.45
2 China Securities Finance Co., Ltd. Special Legal Person 4103.38 2.99
3 Hong Kong Securities Clearing Company Ltd. Northbound Funds 1534.94 1.12
4 Huatai-Pinebridge CSI 300 ETF Fund 1179.20 0.86
5 Ruizhong Life Insurance Co., Ltd. - Own Funds Insurance 1023.39 0.75
6 E Fund CSI 300 Healthcare ETF Fund 859.42 0.63
7 E Fund CSI 300 ETF Fund 843.89 0.62
8 Shanghai Gaoyi Asset Management Partnership - Gaoyi Linshan No.1 Yuanwang Fund General Legal Person 650.00 0.47
9 ChinaAMC CSI 300 ETF Fund 629.78 0.46
10 Harvest CSI 300 ETF Fund 542.88 0.40

5. Concept Sectors

  • Generic Drugs
  • DeepSeek
  • Margin Trading & Securities Lending
  • Insurance Heavy Positions
  • Blue Chip Stocks
  • China Securities Finance & Central Huijin
  • MSCI Constituent
  • Non-Cyclical Stocks
  • SSE 180
  • SSE Mid Cap
  • CSI 300
  • CCTV 50
  • CSI 200
  • CSI 300 Non-Cyclical
  • SOE Reform

Remarks

  • Data update date: 2025-10-30
  • Data source: Public market information